20 years of Cure Parkinson's
We’re here for the cure! This year marks 20 years since Cure Parkinson’s was founded by four people living with Parkinson’s who felt that nobody was taking a cure seriously enough and that there was an urgent need for a focused approach to curative research...
Learn more
Press Release: Phase 2 clinical trial of Type 2 diabetes drug for treatment of Parkinson’s shows positive and promising results
3 April 2024 Results from a one-year, phase 2 clinical trial of the Type 2 diabetes drug lixisenatide suggest that the treatment may slow the progression of motor symptoms in Parkinson’s disease. The study is published on 4 April in The New England Journal of…
Upcoming GBA1 conference in Montreal
Cure Parkinson’s is co-sponsoring a large three-day international conference on June 27th – 29th that will be focused on all aspects of GBA1 research, from basic science to clinical trials.
Time to ROCK-PD
Researchers in Germany are conducting a new phase 2 clinical trial to determine if an existing cardiovascular drug called fasudil, could help people with Parkinson’s.
INSIGHT Conference with PD Warriors 2024
Join global Parkinson’s leaders during World Parkinson’s Awareness Month at INSIGHT to PD, brought to you by PD Warrior, the pioneer behind the world’s most comprehensive Parkinson’s rehabilitation program. INSIGHT into PD is the largest online conference supporting Parkinson’s disease. This is a two-day conference,…
The Movers & Shakers ‘Parky Charter’ petition
We supported the Movers & Shakers, along with Parkinson’s UK and Spotlight YOPD, to call on the government to take action to improve the lives of people with Parkinson’s on World Parkinson’s Day 2024. They’ve relaunched their “Parky Charter” petition for 2025 – join us…